The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life

Clinical and Experimental Immunology

Volumn 162, Issue 3, 2010, Pages 494-499

  Vosters, O ^a   Lombard, C ^a   Andre F ^a   Sana, G ^a   Sokal, E M ^a   Smets, F ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Cord blood; LPS; Newborns; Oligodeoxynucleotide; Peripheral blood mononuclear cell

Indexed keywords

ALPHA INTERFERON; CYTOSINE; GUANOSINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; OLIGODEOXYNUCLEOTIDE; PHOSPHATE; CPG ODN 2216; OLIGODEOXYRIBONUCLEOTIDE;

ARTICLE; CELL ISOLATION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MICROARRAY; SUPERNATANT; UMBILICAL CORD BLOOD; ADULT; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DISEASE PREDISPOSITION; DRUG EFFECT; FETUS BLOOD; GENETICS; IMMUNOLOGY; INFECTION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SECRETION; TIME;

ADULT; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; FETAL BLOOD; HUMANS; INFANT; INFECTION; INTERFERON-ALPHA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; TIME FACTORS;

EID: 79952469185     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04267.x     Document Type: Article

References (37)

1. Wilson CB, Lewis DB. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 1990; 12 (Suppl. 4): S410-20.
2. Siegrist CA. Vaccination in the neonatal period and early infancy. Int Rev Immunol 2000; 19: 195-219.
3. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4: 553-64.
4. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 2005; 11: 113-16.
5. Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999; 20: 330-5.
6. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
7. Danis B, George TC, Goriely S et al. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur J Immunol 2008; 38: 507-17.
8. De Wit D, Olislagers V, Goriely S et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103: 1030-2.
9. Tonon S, Goriely S, Aksoy E et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol 2002; 32: 3118-25.
10. Goriely S, Vincart B, Stordeur P et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166: 2141-6.
11. Goriely S, Van Lint C, Dadkhah R et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 2004; 199: 1011-16.
12. De Wit D, Tonon S, Olislagers V et al. Impaired responses to Toll-like receptor 4 and Toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21: 277-81.
13. Aksoy E, Albarani V, Nguyen M et al. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007; 109: 2887-93.
14. Upham JW, Lee PT, Holt BJ et al. Development of interleukin-12- producing capacity throughout childhood. Infect Immun 2002; 70: 6583-8.
15. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-7.
16. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008; 19: 3-19.
17. Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 2007; 204: 1107-18.
18. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
19. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol 2004; 114: 436-43.
20. Akbar AN, Lord JM, Salmon M. IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation. Immunol Today 2000; 21: 337-42.
21. Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001; 2: 1144-50.
22. Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98: 9237-42.
23. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863-9.
24. Siegal FP, Kadowaki N, Shodell M et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835-7.
25. Bowie AG. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin Exp Immunol 2007; 147: 217-26.
26. Klinman DM. Immunotherapeutic uses of CpG oligodeoxy-nucleotides. Nat Rev Immunol 2004; 4: 249-58.
27. Goldman M. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol 2007; 147: 208-16.
28. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008; 226: 205-18.
29. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008; 121: 1108-11.
30. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005; 141: 10-18.
31. Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005; 116: 16-24. quiz 5.
32. Teig N, Moses D, Gieseler S, Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol 2002; 55: 453-7.
33. de Vries E, de Bruin-Versteeg S, Comans-Bitter WM et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000; 47: 528-37.
34. Gold MC, Donnelly E, Cook MS, Leclair CM, Lewinsohn DA. Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr Res 2006; 60: 34-7.
35. Sun CM, Deriaud E, Leclerc C, Lo-Man R. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005; 22: 467-77.
36. Nguyen M, Leuridan E, Zhang T et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 2010; 5: e10407.
37. Belderbos ME, van Bleek GM, Levy O et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009; 133: 228-37.